Human B cell growth and differentiation in the spleen of immunodeficient mice

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 2929-2936

  Depraetere, S ^a   Verhoye, L ^a   Leclercq, G ^a   Leroux Roels, G ^a  

^a INNOGENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INTERLEUKIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL TRANSFER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNE DEFICIENCY; IMMUNIZATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN;

EID: 0035284746     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.2929     Document Type: Article

References (40)

1. A severe combined immunodeficiency mutation in the mouse
2. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse
3. Transfer of a functional human immune system to mice with severe combined immunodeficiency
4. The biology of the SCID mutation
5. Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes
6. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1
7. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice
8. Murine interleukin 2 receptor β chain blockade improves human leukocyte engraftment in severe combined immunodeficient (SCID) mice
9. Enhanced engraftment of human peripheral blood lymphocytes into anti-murine interferon-γ monoclonal antibody-treated C.B.-17-scid mice
10. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β chain monoclonal antibody in mice
11. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
12. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice
13. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice
14. Human monoclonal antibody production: Current status and future prospects
15. Mouse x human heterohybridomas as fusion partners with human B cell tumors
16. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors
17. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood
18. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand
19. Emv30null NOD-scid mice: An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells
20. In vivo effect of anti-asialo GM1 antibody on natural killer activity
21. Novel surface antigen expressed on dividing cells but absent from nondividing cells
22. + T cells or their membranes
23. Generation of memory B cells and plasma cells in vitro
24. + B cell line
25. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody
26. CD40 expression in malignant plasma cells: Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line
27. Immunologic phenotype in 30 patients with diffuse large-cell lymphoma
28. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies
29. Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice
30. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes
31. T-cell-dependent production of IgG by human cord blood B cells in reconstituted SCID mice
32. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (1DEC-C2B8) in patients with recurrent B-cell lymphoma
33. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice
34. New perspectives on recombinant human antibodies
35. Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries
36. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies
37. Antigen-specific IgG responses from naive human splenocytes: In vitro priming followed by antigen boost in the SCID mouse
38. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans
39. High-avidity human IgG κ monoclonal antibodies from a novel strain of minilocus transgenic mice
40. Double trans-chromosomic mice: Maintenance of two individual human chromosome fragments containing Ig heavy and κ loci and expression of fully human antibodies